Union City, CA, United States of America

Zhixia Li

This inventor holds 1 USPTO granted patent. Top assignee: Hongene Biotech Corporation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhixia Li. Retrieved from https://idiyas.com/inventor/zhixia-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhixia Li: Innovator in Functionalized N-acetylgalactosamine Analogs

Introduction

Zhixia Li is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of functionalized N-acetylgalactosamine analogs. His work focuses on innovative methods that enhance the delivery of therapeutics.

Latest Patents

Zhixia Li holds 1 patent for his invention titled "Functionalized N-acetylgalactosamine analogs." This patent relates to the creation of polyvalent N-acetylgalactosamine analogs, which can be synthesized using various linkers containing functional groups. These analogs are particularly useful in the targeted delivery of oligonucleotide-based therapeutics.

Career Highlights

Li is currently associated with Hongene Biotech Corporation, where he applies his expertise in biochemistry to advance therapeutic technologies. His innovative approach has positioned him as a key figure in his field.

Collaborations

Zhixia Li has collaborated with notable colleagues, including Wing C Poon and Gang Zhao. Their combined efforts contribute to the advancement of research in biochemistry and therapeutic applications.

Conclusion

Zhixia Li's work in functionalized N-acetylgalactosamine analogs showcases his commitment to innovation in biochemistry. His contributions are paving the way for more effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…